UBX Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-03-14 | Dananberg Jamie | officer: Chief Medical Officer | 63,237 | S-Sale | D | 1,005 | 4.00 | 4,020.00 |
| 2023-03-14 | Ghosh Anirvan | director, officer: Chief Executive Officer | 91,025 | S-Sale | D | 1,210 | 4.00 | 4,840.00 |
| 2023-02-02 | Dananberg Jamie | officer: Chief Medical Officer | 64,242 | S-Sale | D | 863 | 4.84 | 4,176.92 |
| 2023-02-02 | Ghosh Anirvan | director, officer: Chief Executive Officer | 92,235 | S-Sale | D | 2,573 | 4.84 | 12,453.32 |
| 2023-01-30 | Ghosh Anirvan | director, officer: Chief Executive Officer | 94,808 | S-Sale | D | 1,140 | 4.45 | 5,073.00 |
| 2022-12-14 | Ghosh Anirvan | director, officer: Chief Executive Officer | 95,948 | S-Sale | D | 1,274 | 2.85 | 3,630.90 |
| 2022-12-14 | Dananberg Jamie | officer: Chief Medical Officer | 65,105 | S-Sale | D | 1,016 | 2.85 | 2,895.60 |
| 2022-11-18 | Nguyen Alexander Hieu | officer: General Counsel and Corporate Secretary | 65,000 | A-Award | A | 65,000 | 2.38 | 154,700.00 |
| 2022-11-18 | Dananberg Jamie | officer: Chief Medical Officer | 65,000 | A-Award | A | 65,000 | 2.38 | 154,700.00 |
| 2022-11-18 | Ghosh Anirvan | director, officer: Chief Executive Officer | 200,000 | A-Award | A | 200,000 | 2.38 | 476,000.00 |
| 2022-11-18 | Sullivan Lynne Marie | officer: CFO & Head of Corp. Dev. | 80,000 | A-Award | A | 80,000 | 2.38 | 190,400.00 |
| 2022-11-03 | Ghosh Anirvan | director, officer: Chief Executive Officer | 97,222 | S-Sale | D | 1,099 | 2.40 | 2,637.60 |
| 2022-09-14 | Dananberg Jamie | officer: Chief Medical Officer | 661,213 | S-Sale | D | 10,923 | 0.48 | 5,243.04 |
| 2022-09-14 | Ghosh Anirvan | director, officer: Chief Executive Officer | 983,210 | S-Sale | D | 13,706 | 0.48 | 6,578.88 |
| 2022-08-01 | Ghosh Anirvan | director, officer: Chief Executive Officer | 996,916 | S-Sale | D | 10,446 | 0.67 | 6,998.82 |
| 2022-06-27 | Dananberg Jamie | officer: Chief Medical Officer | 672,136 | S-Sale | D | 4,398 | 0.59 | 2,594.82 |
| 2022-06-27 | Ghosh Anirvan | director, officer: Chief Executive Officer | 1,007,362 | S-Sale | D | 12,149 | 0.59 | 7,167.91 |
| 2022-06-24 | O'Neill Gilmore Neil | director | 25,000 | A-Award | A | 25,000 | 0.59 | 14,750.00 |
| 2022-06-24 | Samuels Camille D | director | 25,000 | A-Award | A | 25,000 | 0.59 | 14,750.00 |
| 2022-06-24 | Roberts Margo R | director | 25,000 | A-Award | A | 25,000 | 0.59 | 14,750.00 |
| 2022-06-24 | Leonard Keith R | director | 25,000 | A-Award | A | 25,000 | 0.59 | 14,750.00 |
| 2022-06-24 | BERNS PAUL L | director | 25,000 | A-Award | A | 25,000 | 0.59 | 14,750.00 |
| 2022-06-24 | Samar Michael P. | director | 2,055 | A-Award | A | 2,055 | 0.59 | 1,212.45 |
| 2022-06-24 | David Nathaniel E | director | 25,000 | A-Award | A | 25,000 | 0.59 | 14,750.00 |
| 2022-06-21 | Dananberg Jamie | officer: Chief Medical Officer | 676,534 | S-Sale | D | 3,697 | 0.62 | 2,292.14 |
| 2022-06-14 | Dananberg Jamie | officer: Chief Medical Officer | 680,231 | F-InKind | D | 10,530 | 0.63 | 6,633.90 |
| 2022-06-14 | Ghosh Anirvan | director, officer: Chief Executive Officer | 1,019,511 | F-InKind | D | 12,683 | 0.63 | 7,990.29 |
| 2022-05-25 | Samar Michael P. | director | 50,000 | A-Award | A | 50,000 | 0.76 | 38,000.00 |
| 2022-05-15 | Sullivan Lynne Marie | officer: CFO & Head of Corp. Dev. | 33,009 | J-Other | A | 925 | 6.89 | 6,373.25 |
| 2022-05-02 | Ghosh Anirvan | director, officer: Chief Executive Officer | 1,032,194 | F-InKind | D | 7,729 | 0.88 | 6,801.52 |
| 2022-03-31 | Dananberg Jamie | officer: Chief Medical Officer | 690,761 | F-InKind | D | 4,188 | 1.14 | 4,774.32 |
| 2022-03-31 | Ghosh Anirvan | director, officer: Chief Executive Officer | 1,039,923 | F-InKind | D | 14,472 | 1.14 | 16,498.08 |
| 2022-03-14 | Ghosh Anirvan | director, officer: Chief Executive Officer | 1,054,395 | F-InKind | D | 9,272 | 0.88 | 8,159.36 |
| 2022-03-14 | Dananberg Jamie | officer: Chief Medical Officer | 694,949 | F-InKind | D | 10,581 | 0.88 | 9,311.28 |
| 2022-02-09 | Dananberg Jamie | officer: Chief Medical Officer | 183,333 | A-Award | A | 183,333 | 1.06 | 194,332.98 |
| 2022-02-09 | Dananberg Jamie | officer: Chief Medical Officer | 705,530 | A-Award | A | 45,833 | 0.00 | 0.00 |
| 2022-02-09 | Sullivan Lynne Marie | officer: CFO & Head of Corp. Dev. | 200,000 | A-Award | A | 200,000 | 1.06 | 212,000.00 |
| 2022-02-09 | Sullivan Lynne Marie | officer: CFO & Head of Corp. Dev. | 326,785 | A-Award | A | 50,000 | 0.00 | 0.00 |
| 2022-02-09 | Nguyen Alexander Hieu | officer: General Counsel and Corporate Secretary | 183,333 | A-Award | A | 183,333 | 1.06 | 194,332.98 |
| 2022-02-09 | Nguyen Alexander Hieu | officer: General Counsel and Corporate Secretary | 51,041 | A-Award | A | 45,833 | 0.00 | 0.00 |
| 2022-02-09 | Ghosh Anirvan | director, officer: Chief Executive Officer | 566,667 | A-Award | A | 566,667 | 1.06 | 600,667.02 |
| 2022-02-09 | Ghosh Anirvan | director, officer: Chief Executive Officer | 1,063,667 | A-Award | A | 141,667 | 0.00 | 0.00 |
| 2021-12-14 | Dananberg Jamie | officer: Chief Medical Officer | 659,697 | F-InKind | D | 10,614 | 1.63 | 17,300.82 |
| 2021-06-24 | Sullivan Lynne Marie | officer: Chief Financial Officer | 270,833 | A-Award | A | 30,833 | 0.00 | 0.00 |
| 2021-06-24 | Sullivan Lynne Marie | officer: Chief Financial Officer | 123,333 | A-Award | A | 123,333 | 4.18 | 515,531.94 |
| 2021-06-24 | COOPER GRAHAM K | director | 25,000 | A-Award | A | 25,000 | 4.18 | 104,500.00 |
| 2021-06-24 | O'Neill Gilmore Neil | director | 13,425 | A-Award | A | 13,425 | 4.18 | 56,116.50 |
| 2021-06-24 | Burow Kristina | director | 25,000 | A-Award | A | 25,000 | 4.18 | 104,500.00 |
| 2021-06-24 | BERNS PAUL L | director | 25,000 | A-Award | A | 25,000 | 0.00 | 0.00 |
| 2021-06-24 | Roberts Margo R | director | 25,000 | A-Award | A | 25,000 | 0.00 | 0.00 |
| 2021-06-24 | Ghosh Anirvan | director, officer: Chief Executive Officer | 922,000 | A-Award | A | 72,000 | 0.00 | 0.00 |
| 2021-06-24 | Ghosh Anirvan | director, officer: Chief Executive Officer | 290,000 | A-Award | A | 290,000 | 0.00 | 0.00 |
| 2021-06-24 | Samuels Camille D | director | 25,000 | A-Award | A | 25,000 | 4.18 | 104,500.00 |
| 2021-06-24 | David Nathaniel E | director | 11,918 | A-Award | A | 11,918 | 4.18 | 49,817.24 |
| 2021-06-24 | Dananberg Jamie | officer: Chief Medical Officer | 710,875 | A-Award | A | 25,000 | 0.00 | 0.00 |
| 2021-06-24 | Dananberg Jamie | officer: Chief Medical Officer | 100,000 | A-Award | A | 100,000 | 4.18 | 418,000.00 |
| 2021-06-24 | Leonard Keith R | director | 25,000 | A-Award | A | 25,000 | 0.00 | 0.00 |
| 2021-06-24 | Nguyen Alexander Hieu | officer: General Counsel and Corporate Secretary | 20,833 | A-Award | A | 20,833 | 4.18 | 87,081.94 |
| 2021-06-24 | Nguyen Alexander Hieu | officer: General Counsel and Corporate Secretary | 5,208 | A-Award | A | 5,208 | 0.00 | 0.00 |
| 2021-06-21 | Dananberg Jamie | officer: Chief Medical Officer | 685,875 | F-InKind | D | 3,515 | 4.18 | 14,692.70 |
| 2021-03-30 | Dananberg Jamie | officer: Chief Medical Officer | 670,311 | F-InKind | D | 40,564 | 2.95 | 119,663.80 |
| 2021-03-30 | Dananberg Jamie | officer: Chief Medical Officer | 689,390 | F-InKind | D | 2,829 | 5.73 | 16,210.17 |
| 2021-03-09 | Nguyen Alexander Hieu | officer: General Counsel and Corporate Secretary | 250,000 | A-Award | A | 250,000 | 6.69 | 1,672,500.00 |
| 2021-01-29 | Ghosh Anirvan | director, officer: Chief Executive Officer | 850,000 | A-Award | A | 250,000 | 0.00 | 0.00 |
| 2021-01-29 | Ghosh Anirvan | director, officer: Chief Executive Officer | 150,000 | A-Award | A | 150,000 | 5.98 | 897,000.00 |
| 2021-01-29 | David Nathaniel E | director | 50,000 | A-Award | A | 50,000 | 5.98 | 299,000.00 |
| 2020-12-30 | Leonard Keith R | director | 0 | G-Gift | D | 500,000 | 0.00 | 0.00 |
| 2020-12-16 | David Nathaniel E | director | 624,703 | S-Sale | D | 1,700,000 | 5.24 | 8,908,000.00 |
| 2020-12-10 | O'Neill Gilmore Neil | director | 50,000 | A-Award | A | 50,000 | 0.00 | 0.00 |
| 2020-09-13 | Ghosh Anirvan | director, officer: Chief Executive Officer | 600,000 | A-Award | A | 300,000 | 0.00 | 0.00 |
| 2020-09-13 | Ghosh Anirvan | director, officer: Chief Executive Officer | 250,000 | A-Award | A | 250,000 | 2.94 | 735,000.00 |
| 2020-09-13 | Sullivan Lynne Marie | officer: Chief Financial Officer | 240,000 | A-Award | A | 240,000 | 0.00 | 0.00 |
| 2020-09-13 | Azoy Alexander | officer: See Remarks | 135,000 | A-Award | A | 135,000 | 0.00 | 0.00 |
| 2020-09-13 | Dananberg Jamie | officer: Chief Medical Officer | 692,219 | A-Award | A | 240,000 | 0.00 | 0.00 |
| 2020-08-01 | Sullivan Lynne Marie | officer: Chief Financial Officer | 240,000 | A-Award | A | 240,000 | 0.00 | 0.00 |
| 2020-06-22 | Marquess Dan | officer: Chief Scientific Officer | 380,690 | F-InKind | D | 2,483 | 9.67 | 24,010.61 |
| 2020-06-22 | David Nathaniel E | director | 2,324,703 | F-InKind | D | 2,483 | 9.67 | 24,010.61 |
| 2020-06-22 | Goeltz II Robert C. | officer: Chief Financial Officer | 161,027 | F-InKind | D | 2,483 | 9.67 | 24,010.61 |
| 2020-06-22 | Dananberg Jamie | officer: Chief Medical Officer | 452,219 | F-InKind | D | 2,483 | 9.67 | 24,010.61 |
| 2020-06-22 | Leonard Keith R | director | 89,546 | F-InKind | D | 4,711 | 9.67 | 45,555.37 |
| 2020-06-22 | Tompkins Tamara | officer: See Remarks | 42,847 | F-InKind | D | 2,483 | 9.67 | 24,010.61 |
| 2020-06-18 | Leonard Keith R | director | 50,000 | A-Award | A | 50,000 | 9.14 | 457,000.00 |
| 2020-06-18 | COOPER GRAHAM K | director | 25,000 | A-Award | A | 25,000 | 9.14 | 228,500.00 |
| 2020-06-18 | Roberts Margo R | director | 25,000 | A-Award | A | 25,000 | 9.14 | 228,500.00 |
| 2020-06-18 | Lacey David L. | director | 25,000 | A-Award | A | 25,000 | 9.14 | 228,500.00 |
| 2020-06-18 | NELSEN ROBERT | director | 25,000 | A-Award | A | 25,000 | 0.00 | 0.00 |
| 2020-06-18 | BERNS PAUL L | director | 25,000 | A-Award | A | 25,000 | 9.14 | 228,500.00 |
| 2020-06-18 | Burow Kristina | director | 25,000 | A-Award | A | 25,000 | 0.00 | 0.00 |
| 2020-06-18 | Samuels Camille D | director | 25,000 | A-Award | A | 25,000 | 9.14 | 228,500.00 |
| 2020-06-05 | David Nathaniel E | director | 2,327,186 | P-Purchase | A | 3,200 | 8.90 | 28,478.08 |
| 2020-03-30 | Dananberg Jamie | officer: Chief Medical Officer | 454,702 | A-Award | A | 24,255 | 0.00 | 0.00 |
| 2020-03-30 | Dananberg Jamie | officer: Chief Medical Officer | 98,490 | A-Award | A | 98,490 | 5.95 | 586,015.50 |
| 2020-03-30 | Marquess Dan | officer: Chief Scientific Officer | 381,297 | A-Award | A | 24,255 | 0.00 | 0.00 |
| 2020-03-30 | Marquess Dan | officer: Chief Scientific Officer | 98,490 | A-Award | A | 98,490 | 5.95 | 586,015.50 |
| 2020-03-30 | David Nathaniel E | director | 2,323,986 | A-Award | A | 24,255 | 0.00 | 0.00 |
| 2020-03-30 | Goeltz II Robert C. | officer: Chief Financial Officer | 163,510 | A-Award | A | 29,106 | 0.00 | 0.00 |
| 2020-03-30 | Goeltz II Robert C. | officer: Chief Financial Officer | 118,188 | A-Award | A | 118,188 | 5.95 | 703,218.60 |
| 2020-03-30 | Tompkins Tamara | officer: See Remarks | 45,330 | A-Award | A | 24,255 | 0.00 | 0.00 |
| 2020-03-30 | Tompkins Tamara | officer: See Remarks | 98,490 | A-Award | A | 98,490 | 5.95 | 586,015.50 |
| 2020-03-30 | Ghosh Anirvan | director, officer: Chief Executive Officer | 30,000 | A-Award | A | 30,000 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.